Janney Montgomery Scott LLC bought a new stake in Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 106,613 shares of the construction company’s stock, valued at approximately $681,000. Janney Montgomery Scott LLC owned about 0.13% of Aspen Aerogels as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Millennium Management LLC increased its position in shares of Aspen Aerogels by 4,757.8% during the 4th quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company’s stock valued at $19,270,000 after purchasing an additional 1,588,632 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in Aspen Aerogels in the fourth quarter worth approximately $13,122,000. Alyeska Investment Group L.P. bought a new position in Aspen Aerogels during the fourth quarter valued at approximately $9,504,000. Dendur Capital LP purchased a new position in shares of Aspen Aerogels during the fourth quarter worth approximately $9,207,000. Finally, Renaissance Technologies LLC raised its stake in shares of Aspen Aerogels by 472.4% during the fourth quarter. Renaissance Technologies LLC now owns 766,400 shares of the construction company’s stock worth $9,105,000 after acquiring an additional 632,500 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.
Aspen Aerogels Stock Performance
Aspen Aerogels stock opened at $6.11 on Wednesday. The company has a current ratio of 4.22, a quick ratio of 3.53 and a debt-to-equity ratio of 0.40. The firm has a market cap of $501.69 million, a P/E ratio of -1.75 and a beta of 2.66. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $33.15. The firm has a 50-day moving average of $5.88 and a 200-day moving average of $8.08.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on the stock. Oppenheimer cut shares of Aspen Aerogels from an “outperform” rating to a “market perform” rating in a research note on Thursday, May 8th. TD Cowen upgraded shares of Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, March 11th. Finally, Barclays reiterated an “equal weight” rating and issued a $7.00 price objective (down previously from $13.00) on shares of Aspen Aerogels in a report on Thursday, May 29th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $18.44.
Read Our Latest Stock Report on ASPN
Insider Activity at Aspen Aerogels
In related news, CEO Donald R. Young purchased 20,000 shares of Aspen Aerogels stock in a transaction that occurred on Monday, May 12th. The shares were bought at an average price of $5.35 per share, for a total transaction of $107,000.00. Following the completion of the transaction, the chief executive officer directly owned 550,856 shares of the company’s stock, valued at $2,947,079.60. This represents a 3.77% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 3.40% of the company’s stock.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
See Also
- Five stocks we like better than Aspen Aerogels
- 5 discounted opportunities for dividend growth investors
- Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside
- 5 Top Rated Dividend Stocks to Consider
- Breakout Alert: Disney Stock Hits Multi-Year High
- About the Markup Calculator
- Forget IBM: Accenture’s AI Momentum Is Your Next Buy
Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPN – Free Report).
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.